Allison R Eckard
Medical University of South Carolina
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Allison R Eckard as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 07:55 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04019197 · Effects of Semaglutide in HIV-Associated LipohypertrophyCase Western Reserve University · completed · HIV/AIDS, Lipohypertrophy, Obesity · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 07:55 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Effects of GLP-l receptor agonists on cardiometabolic alterations in HIV-associated lipohypertrophyR01DK121619 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · fiscal years 2019 to 2023 · $748,650 awarded in 2023Grant number is on one of their registry trials
- Vitamin D status and HIV-related complications in children and young adultsK23HD069199 · NICHD · MEDICAL UNIVERSITY OF SOUTH CAROLINA · fiscal years 2012 to 2016 · $126,144 awarded in 2016Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 07:55 UTC. The ranking covers the 200 most relevant of 15 PubMed records, and a shared surname and initials can bring in a namesake. All 15 on PubMed
- Effect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapy.J Infect Dis · 2014109 citationsRCR 3.7
- Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial.Lancet Diabetes Endocrinol · 202450 citationsRCR 7.0
- Vitamin D supplementation decreases immune activation and exhaustion in HIV-1-infected youth.Antivir Ther · 201840 citationsRCR 1.9
- Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age.J Pediatric Infect Dis Soc · 201528 citationsRCR 1.1
- Effects of Vitamin D Supplementation on Bone Mineral Density and Bone Markers in HIV-Infected Youth.J Acquir Immune Defic Syndr · 201727 citationsRCR 1.5
- Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial.JAMA Cardiol · 202517 citationsRCR 4.0
- Effects of vitamin D supplementation on carotid intima-media thickness in HIV-infected youth.Virulence · 20188 citationsRCR 0.5
- 7 citationsRCR 0.3
- 7 citationsRCR 4.9
- Effects of cholecalciferol supplementation on serum and urinary vitamin D metabolites and binding protein in HIV-infected youth.J Steroid Biochem Mol Biol · 20175 citationsRCR 0.3